Merck & Co. Inc. announced plans to purchase biopharmaceutical company Tilos Therapeutics.
The deal for the cancer-treatment biotechnology firm could be valued at up to $773 million.
The deal includes an up-front payment and milestone payouts.
Read more from MarketWatch.
Developers say city needs a variety of housing types to meet demand.